Recent JUNS News
- Jupiter Neurosciences Announces Closing of $2.0 Million Registered Direct Offering • GlobeNewswire Inc. • 05/21/2026 09:15:00 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 05/21/2026 04:39:12 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 05/21/2026 01:54:45 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/21/2026 01:51:20 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 05/21/2026 12:14:07 PM
- Jupiter Neurosciences Announces Pricing of $2.0 Million Registered Direct Offering • GlobeNewswire Inc. • 05/20/2026 06:38:00 PM
- Micro-Cap Biotech Stocks Surge After Breakthrough Psychedelics Licensing Announcement • AllPennyStocks.com • 05/20/2026 03:35:00 PM
- PharmAla Biotech Signs Term Sheet for $100 Million U.S. Licensing Deal for ALA-002 MDMA Therapy (MDXXF) • IH Market News • 05/20/2026 03:12:27 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 05/20/2026 02:35:13 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/20/2026 01:45:15 PM
- PharmAla Biotech Signs Term Sheet to License Exclusive U.S. Rights to ALA-002, Its Next-Generation MDMA Therapeutic, to Jupiter Neurosciences, Inc. (NASDAQ: JUNS) in a Transaction Valued at Over $100 Million • GlobeNewswire Inc. • 05/20/2026 12:15:00 PM
- Jupiter Neurosciences Secures $100M Term Sheet for Exclusive U.S. Rights to ALA-002, a Next-Generation MDMA Therapeutic from PharmAla Biotech • GlobeNewswire Inc. • 05/20/2026 11:38:00 AM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 05/14/2026 09:20:53 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/14/2026 09:00:54 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 05/08/2026 08:05:22 PM
- Jupiter Neurosciences, Inc. to Present at The Market Movers Investor Summit • Newsfile • 05/04/2026 03:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/27/2026 04:15:16 AM
- Jupiter Neurosciences, Inc. to Present at Centri Capital Conference on April 14 • Newsfile • 04/14/2026 12:00:00 AM
- Jupiter Neurosciences Appoints Kristopher Fishman and Sanjiv Lal to Nugevia™ Advisory Board • GlobeNewswire Inc. • 04/07/2026 12:00:00 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 04/01/2026 08:45:31 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 04/01/2026 08:38:05 PM
- Life Sciences Virtual Investor Forum Presentations Now Available for Online Viewing • GlobeNewswire Inc. • 03/13/2026 12:35:00 PM
- Life Sciences Virtual Investor Forum Agenda Announced for March 11th & 12th • GlobeNewswire Inc. • 03/10/2026 02:21:44 PM
- Jupiter Neurosciences to Present at BIO Investment and Growth Summit 2026 • GlobeNewswire Inc. • 03/02/2026 01:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/27/2026 09:30:55 PM
